Insulet (PODD) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 12.92% |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 322.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322.22% |
| Mar 31, 2026 | 156.62% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | 13.03% |
| Jun 30, 2025 | -88.07% |
| Mar 31, 2025 | -31.07% |
| Dec 31, 2024 | -2.61% |
| Sep 30, 2024 | 49.33% |
| Jun 30, 2024 | 590.84% |
| Mar 31, 2024 | 116.39% |
| Dec 31, 2023 | 508.24% |
| Sep 30, 2023 | 1,098.08% |
| Jun 30, 2023 | 178.00% |
| Mar 31, 2023 | -14.39% |
| Dec 31, 2022 | -41.78% |
| Sep 30, 2022 | -141.27% |
| Jun 30, 2022 | -40.00% |
| Dec 31, 2021 | 270.76% |
| Sep 30, 2021 | 8.62% |
| Jun 30, 2021 | -273.61% |